Latest News

Scientists identify a new drug target for dry age-related macular degeneration

Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that the blood protein vitronectin is a promising drug target for dry age-related macular degeneration (AMD), a leading cause of vision loss in Americans 60 years of age and older. The study, published in the Proceedings of the National Academy of Sciences (PNAS), also holds implications for Alzheimer’s and heart disease, which are linked to vitronectin.

Source link

Related posts

Worldwide Intrapartum Monitoring Devices Market Outlook (2019-2023) with Arjo, GE Healthcare, Koninklijke Philips, Medtronic, Natus Medical, and The Cooper Companies Dominating –


New Speaker Is Smart Enough To Detect Cardiac Arrest, Call For Help


Novel dual stem cell therapy improving cardiac regeneration


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World